AF
BMY icon

Avanza Fonder’s Bristol-Myers Squibb BMY Stock Holding History

Avanza Fonder’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Buy
210,840
+11,724
+6% +$673K 0.26% 70
2026
Q1 		$12.1M Sell
199,116
-1,670
-0.8% -$97.4K 0.33% 60
2025
Q4 		$10.8M Sell
200,786
-2,076
-1% -$99.9K 0.27% 72
2025
Q3 		$9.15M Buy
202,862
+10,406
+5% +$486K 0.24% 72
2025
Q2 		$8.91M Buy
192,456
+422
+0.2% +$20.7K 0.26% 69
2025
Q1 		$11.4M Sell
192,034
-26,192
-12% -$1.53M 0.38% 50
2024
Q4 		$12.3M Buy
+218,226
New +$12.2M 0.37% 44

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Avanza Fonder's BMY Position: Q2 2026 in Review

Avanza Fonder increased its Bristol-Myers Squibb (BMY) stake by 5.9% in Q2 2026, buying an estimated $673K and bringing the position to 210,840 shares worth $12.1M. The position accounts for 0.26% of the portfolio, ranked #70.

Avanza Fonder first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.3M in Q4 2024. 2,512 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Avanza Fonder held 210,840 shares of Bristol-Myers Squibb worth $12.1M as of Q2 2026.
  • Avanza Fonder bought 11,724 Bristol-Myers Squibb shares in Q2 2026, an estimated $673K.
  • Bristol-Myers Squibb made up 0.26% of Avanza Fonder's portfolio in Q2 2026, its #70 holding.
  • Avanza Fonder first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Avanza Fonder's Bristol-Myers Squibb position peaked at $12.3M in Q4 2024.
  • 2,512 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.